Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
Completed
Conditions studied: Breast Cancer
In brief
RATIONALE: Studying samples of urine and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This study is looking at urine and blood samples in women with newly diagnosed breast cancer.
Key facts
- Study ID
- NCT00766454
- Run by
- Wake Forest University Health Sciences
- People needed
- 1104
- Starts
- 1998-11-01
- Expected to finish
- 2010-01-01
- Last updated by the study team
- 2017-08-01
Who can join
Age: any, up to 120. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Newly diagnosed breast cancer
- Planning to undergo a diagnostic biopsy or surgery
- Must have tumor tissue available
- Hormone receptor status not specified
- More than 6 months since prior chemotherapy or radiotherapy
- Pre- or post-menopausal
You may not qualify if…
- Psychiatric history that would preclude giving informed consent
Where it is running
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.